Warm Springs Advisors Inc. acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 1,898 shares of the medical equipment provider's stock, valued at approximately $991,000.
Several other institutional investors also recently bought and sold shares of ISRG. Wesbanco Bank Inc. grew its stake in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after buying an additional 19 shares during the period. Raleigh Capital Management Inc. grew its stake in Intuitive Surgical by 8.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 318 shares of the medical equipment provider's stock worth $166,000 after buying an additional 24 shares during the period. Galvin Gaustad & Stein LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth approximately $218,000. FCG Investment Co grew its stake in Intuitive Surgical by 9.9% during the fourth quarter. FCG Investment Co now owns 2,362 shares of the medical equipment provider's stock worth $1,233,000 after buying an additional 212 shares during the period. Finally, Conway Capital Management Inc. grew its stake in Intuitive Surgical by 8.4% during the fourth quarter. Conway Capital Management Inc. now owns 4,951 shares of the medical equipment provider's stock worth $2,584,000 after buying an additional 382 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research analysts have recently weighed in on ISRG shares. Leerink Partners upped their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Bernstein Bank upped their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. Robert W. Baird decreased their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price target on the stock. Finally, Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $596.05.
Check Out Our Latest Analysis on ISRG
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now owns 6,371 shares in the company, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction on Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the transaction, the chief financial officer now directly owns 7,162 shares of the company's stock, valued at approximately $4,060,424.28. The trade was a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,700 shares of company stock valued at $16,865,621. 0.70% of the stock is currently owned by corporate insiders.
Intuitive Surgical Stock Performance
Shares of NASDAQ:ISRG traded up $10.65 during trading hours on Tuesday, hitting $550.19. 1,243,739 shares of the company's stock traded hands, compared to its average volume of 1,645,228. Intuitive Surgical, Inc. has a 52 week low of $396.15 and a 52 week high of $616.00. The company's fifty day simple moving average is $512.50 and its two-hundred day simple moving average is $538.12. The company has a market cap of $197.20 billion, a price-to-earnings ratio of 85.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the firm posted $1.50 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.